Stocks · News reference
US Stocks Mixed; American Express Shares Fall Following Q2 Results
US stocks mixed, Dow Jones up 0.2%. Real estate shares up 1.3%. American Express falls 6%. Ohmyhome, LiveWire, Vivakor surge. Robin Energy, RADIOPHARM, Codexis down.
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
American Express Looks Beyond Cards With New Business Savings Offering
American Express launches a high-yield business savings account offering 2.95% APY with no minimum balance or fees, integrating it with existing business checking and card products. The company plans to add rewards deposit features and AI-powered payroll tools to create a comprehensive business finance platform. The move aims to deepen customer relationships and create an additional funding source through deposit growth.
Warren Buffett, Donald Trump Bet on Same 17 Stocks — Some Might Surprise You
The investment portfolio of President Donald Trump and Berkshire Hathaway have 17 stocks in common. Here's a look at the list.
My Top 5 Favorite Stocks for an Uncertain Market
The article recommends five resilient stocks suitable for uncertain market conditions: Johnson & Johnson (pharmaceutical and medtech leader with 28 billion-dollar products), Vertex Pharmaceuticals (cystic fibrosis treatment market leader with pipeline expansion), Costco (essential goods retailer with high membership renewal rates), Coca-Cola (beverage company with strong brands and free cash flow), and American Express (payment card company with affluent customer base). These companies offer stability through essential products, strong market positions, and consistent dividend payments.
Piper Sandler Maintains Overweight on Codexis, Lowers Price Target to $8
Piper Sandler analyst Kashy Harrison maintains Codexis (NASDAQ:CDXS) with a Overweight and lowers the price target from $9 to $8.
Codexis Affirms FY2026 Sales Guidance of $72.000M-$76.000M vs $74.099M Est
Codexis (NASDAQ:CDXS) affirms FY2026 sales outlook from $72.000 million-$76.000 million to $72.000 million-$76.000 million vs $74.099 million estimate.